Intranasal delivery of rotigotine to the brain with lactoferrin-modified PEG-PLGA nanoparticles for Parkinson’s disease treatment

Sustainable and safe delivery of brain-targeted drugs is highly important for successful therapy in Parkinson’s disease (PD). This study was designed to formulate biodegradable poly(ethylene glycol)–poly(lactic-co-glycolic acid) (PEG-PLGA) nanoparticles (NPs), which were surface-modified with lactof...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Int J Nanomedicine
Päätekijät: Bi, Chenchen, Wang, Aiping, Chu, Yongchao, Liu, Sha, Mu, Hongjie, Liu, Wanhui, Wu, Zimei, Sun, Kaoxiang, Li, Youxin
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Dove Medical Press 2016
Aiheet:
Original Research
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5153272/
https://ncbi.nlm.nih.gov/pubmed/27994458
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IJN.S120939
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia